News and Analysis

Patient centricity in generic drug development involves the understanding and addressing of patients’ needs and preferences. Key aspects include keen patient engagement, patient-friendly formulation design,

President-Elect Donald Trump nominated Martin A. Makary, a surgeon and public policy researcher from the Johns Hopkins University, as the next Commissioner of the FDA.